ProQR Therapeutics

Home » ProQR Therapeutics

Secondary

ProQR Therapeutics

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as cystic fibrosis, Leber’s congenital amaurosis 10 and dystrophic epidermolysis bullosa.

Symbol

PRQR

Last Closing Price
$3.48

Shares
5,000,000

Effective Date
November 14, 2017

Underwriters
H.C. Wainwright

To view the prospectus for ProQR Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253